These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3293936)

  • 1. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Beta-lactam antibiotics.
    Lietman PS
    Chest; 1988 Aug; 94(2 Suppl):115S-120S. PubMed ID: 3293936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy of pulmonary infections in cystic fibrosis. Dosage schedules and duration of treatment.
    Strandvik B
    Chest; 1988 Aug; 94(2 Suppl):146S-149S. PubMed ID: 3396437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary infection and antibiotic treatment in patients with cystic fibrosis.
    Chest; 1988 Aug; 94(2 Suppl):97S-169S. PubMed ID: 3396440
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of antibiotics in cystic fibrosis patients with particular reference to the bronchopulmonary tree (review).
    Bergogne-Berezin E
    Infection; 1987; 15(4):288-94. PubMed ID: 3312023
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.
    Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA
    Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J
    Chest; 1988 Aug; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
    Michel BC
    Chest; 1988 Aug; 94(2 Suppl):129S-140S. PubMed ID: 3293939
    [No Abstract]   [Full Text] [Related]  

  • 8. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic treatment. Aerosol therapy.
    Hodson ME
    Chest; 1988 Aug; 94(2 Suppl):156S-162S. PubMed ID: 3396438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial therapy against Staphylococcus aureus, Pseudomonas aeruginosa, and Pseudomonas cepacia.
    Geddes DM
    Chest; 1988 Aug; 94(2 Suppl):140S-145S. PubMed ID: 3293940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotics in the treatment of cystic fibrosis].
    Stoppelman MR
    Maandschr Kindergeneeskd; 1969 Oct; 37(4):113-9. PubMed ID: 5345411
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of antibiotics in cystic fibrosis: a narrative review.
    Castagnola E; Cangemi G; Mesini A; Castellani C; Martelli A; Cattaneo D; Mattioli F
    Int J Antimicrob Agents; 2021 Sep; 58(3):106381. PubMed ID: 34157401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious Diseases Pharmacotherapy for Children With Cystic Fibrosis.
    Molloy L; Nichols K
    J Pediatr Health Care; 2015; 29(6):565-78; quiz 579-80. PubMed ID: 26498903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising β -lactam Dosing in Neonates: A Review of Pharmacokinetics, Drug Exposure and Pathogens.
    Fuchs A; Li G; van den Anker JN; Bielicki J
    Curr Pharm Des; 2017; 23(38):5805-5838. PubMed ID: 28950814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of two dosage regimens of ciprofloxacin during a two-week therapeutic trial in patients with cystic fibrosis.
    Stutman HR; Shalit I; Marks MI; Greenwood R; Chartrand SA; Hilman BC
    Am J Med; 1987 Apr; 82(4A):142-5. PubMed ID: 3555028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations.
    Lindsay CA; Bosso JA
    Clin Pharmacokinet; 1993 Jun; 24(6):496-506. PubMed ID: 8513651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home treatment of pulmonary infection in cystic fibrosis.
    Kuzemko JA
    Chest; 1988 Aug; 94(2 Suppl):162S-166S. PubMed ID: 3396439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections.
    Drusano GL; Craig WA
    J Chemother; 1997 May; 9 Suppl 3():38-44. PubMed ID: 9248979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early lung disease in cystic fibrosis.
    Grasemann H; Ratjen F
    Lancet Respir Med; 2013 Apr; 1(2):148-57. PubMed ID: 24429095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.